Pages that link to "Q35965218"

The following pages link to Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis (Q35965218):

Displaying 17 items.

• Modeling HIV vaccine trials of the future (Q30393307) (← links)
• Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller (Q33809708) (← links)
• Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes (Q33821090) (← links)
• Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design (Q33867299) (← links)
• Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection (Q36816564) (← links)
• Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel. (Q36844746) (← links)
• Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide (Q38644317) (← links)
• The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion (Q38849706) (← links)
• Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT. (Q40281007) (← links)
• Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines (Q42334798) (← links)
• The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil (Q51731801) (← links)
• Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018. (Q52571189) (← links)
• Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018 (Q59355921) (← links)
• Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men (Q61811072) (← links)
• Cross-sectional HIV incidence estimation in an evolving epidemic (Q92204118) (← links)
• Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection (Q92883670) (← links)
• Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women (Q98177674) (← links)